
Johann de Bono,
Professor, Head of the Division of Clinical Studies, The Institute for Cancer Research, (ICR) and Royal Marsden, London, UK

Richard J. Cote, M.D. FRCPath, FCAP
Professor and Incoming Chair, Department of Pathology and Immunology, Pathologist-in-Chief, Barnes-Jewish Hospital, Washinghton University in St Louis, St Louis, USA

Massimo Cristofanilli, MD, FACP
Chief, Breast Medical Oncology
Associate Director of Precision Medicine, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Scientific Director, the Englander Institute of Precision Medicine, Co-Leader, Meyer Cancer Center Management Team
Associate Director of Precision Medicine, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Scientific Director, the Englander Institute of Precision Medicine, Co-Leader, Meyer Cancer Center Management Team

Caroline Dive, PhD
Professor, Deputy Director Cancer Research UK Manchester Institute, Senior Group Leader Clinical & Experimental Pharmacology, The University of Manchester, UK

Ellen Heitzer, PhD
Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria

Michail Ignatiadis, MD, PhD
Director, Breast Medical Oncology Clinic & Program, Medical Oncology
Department, Institut Bordet, Associate Professor, Université Libre de
Bruxelles, Chair,
Breast Cancer Group, EORTC, Belgium

Peter Kuhn, PhD
Dean’s Professor of Biological
Sciences and Professor of Medicine, Biomedical Engineering, Aerospace &
Mechanical Engineering, and Urology, USC
Michelson CSI-Cancer, Los Angeles, California, USA

Evi Lianidou, PhD
Professor of Analytical Chemistry – Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece

Mike Makrigiorgos, PhD
Professor and Director, Medical Physics and Biophysics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA

Jean-Yves Pierga, MD, PhD
Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France

Nikolas Stoecklein, MD
Professor, Experimental Surgical Oncology, Heinrich Heine University, Düsseldorf, Germany

Andreas Trumpp, PhD
Head, Division of Stem Cells and Cancer at the German Cancer Research Center (DKFZ), Heidelberg, Germany